Alternatives to Goldspan Health

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• $30/mo cheaper than Goldspan Health
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• $30/mo cheaper than Goldspan Health
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

• $30/mo cheaper than Goldspan Health
• has an oral option if you would rather not inject
• scores 78/100 against Goldspan Health's 31

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

• $33/mo cheaper than Goldspan Health
• scores 89/100 against Goldspan Health's 31

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

• $30/mo cheaper than Goldspan Health
• offers FDA-approved brand pens, not just compounded
• scores 71/100 against Goldspan Health's 31

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

• $30/mo cheaper than Goldspan Health
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Three pages of this site quote three different prices for the same treatment: the homepage says semaglutide starts at $169 a month, the packages page shows $169 for month one and $199 from month two, and the semaglutide page says the program "typically ranges from $200-$550 per month" — a ceiling nothing on the site comes near. The packages page is the one to trust, and to its credit every plan total on it recomputes to the exact dollar. It also, on the oral semaglutide cards, tells you that what you will receive is tirzepatide.

• $30/mo cheaper than Goldspan Health
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Pallas Health carries both routes at once — compounded semaglutide at roughly $199 a month and tirzepatide at $299, alongside genuine FDA-approved Zepbound at $1,069, Ozempic at $1,299 and Wegovy and Mounjaro at $1,349, all cash-pay on one platform. The price is flat at every dose, answered directly in its own FAQ, and the clinician, dose adjustments, check-ins and messaging are inside that figure with no membership fee layered on. Two clinicians are named and both verify as active in the federal NPI registry, the LegitScript seal is genuine rather than a self-hosted image, and there is a real refund policy — full refund if a clinician declines you, a $5 processing fee on a qualifying cancellation. Two caveats matter for a household budget: billing lands every 12 weeks in $597 and $897 blocks rather than monthly, so the advertised per-month figures are Pallas's own averages, and the compounding pharmacy is never named. There is also no postpartum, breastfeeding or PCOS content on the site at all.

• $30/mo cheaper than Goldspan Health
• offers FDA-approved brand pens, not just compounded
• scores 65/100 against Goldspan Health's 31

Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

• $80/mo cheaper than Goldspan Health
• has an oral option if you would rather not inject
• scores 80/100 against Goldspan Health's 31